Edwards Lifesciences Corporation (FRA:EWL)

Revenue

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Transcatheter Aortic Valve Replacement Revenue	4.36B	4.11B
Transcatheter Mitral and Tricuspid Therapies Revenue	500.00M	352.10M
Surgical Structural Heart Revenue	1.02B	981.30M
Revenue (Total)	5.88B	5.44B

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
United States Revenue	3.45B	3.21B
Europe Revenue	1.45B	1.32B
Japan Revenue	353.10M	339.80M
Rest of World Revenue	630.10M	572.00M
Revenue (Total)	5.88B	5.44B

Updated Sep 30, 2025. Data Source: Fiscal.ai.